【Abstract】Objective: To observe the efficacy of cupping combined with oral administration of Huoxue Qufeng granules in the treatment of vitiligo. Methods: 162 cases were randomly divided into a study group and a control group, 84 cases in the study group were treated with cupping combined with oral administration of Huoxue Qufeng granules, and 78 cases in the control group were treated with cupping alone. Results: The cure rate of the study group was 84.5%, and the total effective rate was 98.8%. The cure rate of the control group was 30.8%, and the total effective rate was 56.4%. The recovery rate and effective rate of the study group were higher than those of the control group, and the difference in curative effect between the two groups was statistically significant (P<0.05). Conclusion: Cupping combined with oral administration of Huoxue Qufeng Granules is effective in treating vitiligo.

   Vitiligo is a common acquired disease of depigmentation. It is characterized by melanocytes in the epidermis, mucous membranes and other tissues. The incidence rate is 0.5% to 2%. There is no obvious ethnic or gender difference. Its incidence may be related to heredity, Neuroendocrine and autoimmunity are related to many factors. At present, there are many treatment methods for vitiligo, but the effect is poor. In recent years, cupping therapy has achieved certain effects in the treatment of vitiligo [1]. Huoxue Qufeng Granules is a preparation in our hospital, which is mainly used for the treatment of multiple types of vitiligo with significant curative effect [2]. Our hospital has used cupping combined with oral administration of Huoxue Qufeng granules to treat vitiligo, and the results are reported as follows.

   1 Materials and methods

   1.1 General information

   The 162 patients who visited our hospital from March 2015 to May 2015 were selected as the research objects. With the consent of the patients, they were randomly divided into two groups according to the order of visits. Among them, the study group has 84 cases and 39 males. There were 45 females, aged 11 to 49 years old, with an average of 24.32 years old, with a course of 1-20 years and an average course of 5.24 years. In the control group, there were 78 cases, 36 males and 42 females, aged from 10 to 50 years, with an average of 23.19, the course of disease was 1 to 18 years, and the average course of disease was 4.36 years.

   1.2 Exclusion criteria

①Patients with high fever, convulsions and blood coagulation disorders; ②Patients with skin allergies and pregnant women; ③Patients with mental illness and severe heart, liver, and kidney damage; ④Patients who have received other topical preparations for the treatment of vitiligo 2 weeks ago.